GlassScriptPhysician profile
Mark Eaton
NPI 1629070495
$8,734.25
in general payments reported to CMS, 2019-2025
33 companies · $2,349 in 2025
The $2,349 reported for 2025 was more than what 80% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,102 · 2020: $212 · 2021: $144 · 2022: $1,185 · 2023: $1,935 · 2024: $1,807 · 2025: $2,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,798 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,797.71 |
| Education | $293.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,564.36 | 2019-2025 | Skyrizi, Rinvoq |
| Janssen Biotech, INC. | $1,040.34 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $849.66 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $555.05 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $530.81 | 2019-2025 | |
| Genzyme Corporation | $481.44 | 2020-2025 | |
| Galderma Laboratories, L.P. | $469.03 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Leo Pharma INC. | $406.87 | 2022-2025 | Adbry, Anzupgo |
| Pfizer INC. | $385.96 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $374.58 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $293.57 | 2019-2025 | Ilumya |
| Amgen INC. | $251.16 | 2019-2025 | Otezla, Otezla |
| Almirall LLC | $208.51 | 2019-2025 | Klisyri, Seysara |
| Incyte Corporation | $156.63 | 2022-2025 | Opzelura |
| Dermavant Sciences, INC. | $156.28 | 2023-2024 | Vtama |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $146.60 | 2023-2025 | Zoryve |
| Ucb, INC. | $138.98 | 2024-2025 | Bimzelx |
| Celgene Corporation | $113.01 | 2019 | |
| Strata Skin Sciences, INC. | $97.73 | 2023-2025 | Xtrac |
| Epi Health, LLC | $74.19 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $71.61 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $71.21 | 2019-2023 | |
| Organon LLC | $60.39 | 2025 | Vtama |
| Aclaris Therapeutics, INC. | $51.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.44 | 2023 | Spevigo |
| Verrica Pharmaceuticals INC. | $24.85 | 2024 | Ycanth |
| Dermira, INC. | $20.45 | 2019 | |
| Vyne Pharmaceuticals INC. | $19.74 | 2020 | |
| Sebela Pharmaceuticals INC. | $17.69 | 2023 | Naftin |
| Allergan, INC. | $16.59 | 2019 | |
| Biofrontera INC. | $15.10 | 2024 | Ameluz, Xepi, Bf-Rhodoled |
| Mission Pharmacal Company | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Eaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.